Life Sciences Trend Analysis 2013

DENMARK

About Us

The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www.biotechgate.com

The Scandinavian Life Sciences Database is a part of the global Biotechgate and is brought to you in partnership with SwedenBIO, Stockholm-Uppsala Life Science and Business Region Göteborg, Copenhagen Capacity and Invest in Skane.

Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www.venturevaluation.com

Status of the Sector

2012 Statistics

Denmark 2013 Statistics

133 Total Biotech Companies 148

55 Biotech - Therapeutics 68

68 Biotech - R&D Services 69

10 Biotech - Other 11

96% Percentage of SME's 93%

8% Percentage of Publicly Owned Companies 6%USD 115 M in

2011 Financing/Capital Raised USD 49 M in 2012

58 Licensing Opportunities

Key Activities of Biotechnology Companies

Historical DataSubsector 201

3201

2Genomics and Proteomics 5% 6%Contract Research and Manufacturing

14% 15%

Diagnostics and Analytical Services

17% 16%

Drug Delivery 6% 6%Other Services and Suppliers 18% 20%Therapeutics 29% 24%Other 11% 13%

Contract Re-search and

Manufacturing14%

Diagnostics and Analyt-ical Services

17%Drug Delivery

6%

Genomics and Proteomics

5%

Other Services and Suppliers

19%

Therapeutics29%

Other11%

2013 Data

Company Foundation Timeline

19951996

19971998

19992000

20012002

20032004

20052006

20072008

20092010

20112012

0

2

4

6

8

10

12

14

1 2 35 6

4 5

1

64 4 3

5

1

2 4

1

1

2

3

5

3

33 4

1

1 2

1

1

1

2

Biotechnology - Therapeutics and DiagnosticsBiotechnology / R&D ServicesBiotechnology - other

Year

No.

of

Com

pani

es F

ound

ed

Company Ownership

Historical DataSubsector 201

32012

Private/ Independent

82% 78%

Public 6% 8%Subsidiary 12% 14%

Private / inde-pendent

82%

Public6%

Subsidiary12%

2013 Data

Sources of Company Foundations

Historical DataCompany Foundation 2013 2012Independent foundation 51% 58%Merger 3% 4%Spin-off from company 4% 5%Spin-off from public institution / NPO 1% -Spin-off from university 7% 6%Subsidiary 14% 23%Other 3% 3%

Undisclosed17%

Independent foundation

51%

Merger3%Spin-off from

company3%

Spin-off from public institu-

tion / NPO1%

Spin-off from university

7%

Subsidiary14%

Other3%

2013 Data

Number of Employees

Historical DataNo. of Employees 2013 20121-10 41% 54%11-50 38% 31%51-200 14% -Greater than 200 7% 6%

1-10:41%

11-50:38%

51-200:14%

201+:7%

2013 No. of Employees

Products in the Pipeline

2013

2012

2013

2012

2013

2012

2013

2012

Prec

linica

lPh

ase

IPh

ase

IIPh

ase

III

0 10 20 30 40 50 60 70 80

76

72

41

39

45

36

13

11

No. of Products

Financing Rounds in Denmark & 3 Major Financing Rounds

Financing for 2012/2013 Private Biotech CompaniesMajor Financings in 2012/2013 Sector USD

M

Egalet Ltd. Biotech – Therapeutics & Diagnostics 14

Nuevolution A/S Biotech – R&D 13

Santaris Pharma A/S Biotech – Therapeutics & Diagnostics 12

2007 2008 2009 2010 2011 2012050

100150200

02468

Financing ValueNumber of Financings

Half Yearly

Fina

ncin

g V

alue

USD

M

Num

ber

of F

undi

ng

Rou

nds

Biotechnology in Selected Countries

About Biotechgate

Biotechgate contains over 29’000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data.

To register for free or learn more about the different subscription options, please visit www.biotechgate.com.

Terms of Use

The “Denmark Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at www.biotechgate.com. The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof.

The use of the figures and graphs provided in this report is free of charge for any presentations as long as www.biotechgate.com is clearly cited as the source. For all other uses please contact us for terms and conditions.

Biotechgatec/o Venture Valuation VV AGKasernenstrasse 11 +41 (43) 321 86 608004 Zurich info@venturevaluation.comSwitzerland www.venturevaluation.com